| General Information |
| Business: |
(Incorporated in Nevada)
Note: This is NOT an IPO. This is a public offering conducted in conjunction with a NASDAQ uplisting from the OTC market, where Cardiff Lexington’s stock trades under the symbol “CDIX” – according to the prospectus. The company plans to list on the NASDAQ under the “CDIX” symbol. The company had previously filed for an IPO in July 2023; that filing was withdrawn in March 2025.
We are a holding company with a focus on the healthcare sector. We acquire and build clinics that specialize in orthopedics, spine care and pain management.
We conduct our business through our subsidiaries: Nova, which runs specialty and ancillary care facilities in Florida and Georgia for traumatic injury patients, and Edge View, a real estate subsidiary with undeveloped land in Idaho.
Note: Net loss and revenue are for the 12 months that ended Sept. 30, 2025.
(Note: Cardiff Lexington Corp. filed its S-1 for its small public offering/NASDAQ uplisting on Dec. 15, 2025, with plans to raise $7 million.)
|
| Industry: |
Office & Clinics of Doctors of Medicine |
| Employees: |
17 |
| Founded: |
1986 |
| Contact Information |
| Address |
3753 Howard Hughes Parkway, Suite 200 Las Vegas, NV 89169 |
| Phone Number |
(844) 628-2100 |
| Web Address |
http://www.cardifflexington.com/ |
| View Prospectus: |
Cardiff Lexington (Uplisting) |
| Financial Information |
| Market Cap |
|
| Revenues |
$11.89 mil (last 12 months) |
| Net Income |
$-3.73 mil (last 12 months) |
| IPO Profile |
| Symbol |
CDIX |
| Exchange |
NASDAQ |
| Shares (millions): |
0.0 |
| Price range |
$0.00 - $0.00 |
| Est. $ Volume |
$7.0 mil |
| Manager / Joint Managers |
R.F. Lafferty & Co. |
| CO-Managers |
|
| Expected To Trade: |
|
|
Status:
|
TBA |
| Quiet Period Expiration Date: |
Available only to Subscribers |
| Lock-Up Period Expiration Date: |
Available only to Subscribers |
| SCOOP Rating |
Available only to Subscribers |
| Rating Change |
Available only to Subscribers |
